945 reports of this reaction
3.5% of all HYDROXYZINE HYDROCHLORIDE ORAL reports
#1 most reported adverse reaction
PRURITUS is the #1 most commonly reported adverse reaction for HYDROXYZINE HYDROCHLORIDE ORAL, manufactured by ANI Pharmaceuticals, Inc.. There are 945 FDA adverse event reports linking HYDROXYZINE HYDROCHLORIDE ORAL to PRURITUS. This represents approximately 3.5% of all 26,851 adverse event reports for this drug.
Patients taking HYDROXYZINE HYDROCHLORIDE ORAL who experience pruritus should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PRURITUS is moderately reported among HYDROXYZINE HYDROCHLORIDE ORAL users, representing a notable but not dominant share of adverse events.
In addition to pruritus, the following adverse reactions have been reported for HYDROXYZINE HYDROCHLORIDE ORAL:
The following drugs have also been linked to pruritus in FDA adverse event reports:
PRURITUS has been reported as an adverse event in 945 FDA reports for HYDROXYZINE HYDROCHLORIDE ORAL. This does not prove causation, but indicates an association observed in post-market surveillance data.
PRURITUS accounts for approximately 3.5% of all adverse event reports for HYDROXYZINE HYDROCHLORIDE ORAL, making it one of the most commonly reported side effect.
If you experience pruritus while taking HYDROXYZINE HYDROCHLORIDE ORAL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.